CEND Annual Symposium
The 14th Annual CEND Symposium was a success!
Emerging and neglected diseases are a group of debilitating and often deadly infections. As a group, these diseases are poorly understood and generally lack effective tools for prevention, control, and treatment. CEND Annual Symposium aims to strengthen connections between San Francisco Bay Area scientists working on infectious diseases of global health importance and the broader global health research, product development, and advocacy communities. The symposium features a dynamic list of invited speakers from around the world, including scientists from developing countries. Participants include academic researchers from UC Berkeley, UCSF, Stanford, UC Davis as well as representatives from local biotechnology and pharmaceutical companies and global health nonprofits.
The focus of the 14th Annual Symposium was Fundamental Mechanisms, Breakthrough Therapies and Beyond. We were finally back in-person, which facilitated lively discussions amongst students, faculty, speakers, and other guests on topics ranging from circadian rhythms in malaria parasites to vaccine development for tuberculosis control. At the end, CEND Fellows, PREP Scholars, and other Berkeley students presented posters on their research projects, fielding thoughtful questions from audience members.
- Filipa Rijo-Ferreria, PhD, Msc | UC Berkeley
- Matt Welch, PhD | UC Berkeley
- Julia Schaletzky, PhD | UC Berkeley
- John Link, PhD | Gilead Sciences
- Rhea Coler, PhD, Msc | University of Washington
- Thierry Diagana, PhD | Novartis
- Judd Walson, MD, MPH | Johns Hopkins University
- Delali Attiogbe Attipoe, MB, MBA | Drugs for Neglected Diseases initiative
THE 13TH ANNUAL CEND SYMPOSIUM
The COVID-19 pandemic has brought the need for better integration of science and policy in a sharp focus. The 13th Annual CEND Symposium "Rapid innovation in a highly regulated space - what can we learn from COVID-19 for pandemic preparedness?" aimed to provide a forum for interdisciplinary thought exchange and development of ideas about how to best harness academic innovation and reserve capacity, and how to develop regulatory frameworks in times of crisis.
This two-day conference featured lectures from thought leaders in drug development, health policy, and other relevant fields, as well as workshops to develop tangible ideas for publication in a conference report. Videos from the 13th Annual CEND Symposium are available on CEND's Youtube channel.
THE 12TH ANNUAL SYMPOSIUMThe focus of the 12th Annual Symposium is: Tackling Emerging Infectious Diseases - Ebola, Fungal, HLB.
- Heinz Feldmann, MD, PhD | National Institutes of Health
- Danielle Porter, PhD | Gilead Sciences
- Jonna Mazet, DVM, MPVM, MhD | UC Davis
- Anders Näär, PhD | UC Berkeley
- Hailing Jin | UC Riverside
- Melanie Barnett, PhD | Stanford University
- Carolyn M. Slupsky, PhD | UC Davis
- Gitta Coaker, PhD | UC Davis
- Manu Prakash, PhD | Stanford University
- Matthew Lewin, MD, PhD | Ophirex
THE 11TH ANNUAL SYMPOSIUM
"Molecular Diagnostics, Antibiotic Resistance, and Helminthic Diseases” The 11th annual CEND symposium addressed three core themes: Molecular Diagnostics, Antibiotic Resistance, and Helminthic Diseases. During each of the three sessions, three speakers presented scientific research projects, product development, and policy. Topic-specific panels at the end of the session allowed the audience to pose questions to all three of the speakers at once.
For a recap of the 11th Annual Symposium, please follow this link.